Wellesley Pharmaceuticals' Unattributed - II Round

Wellesley Pharmaceuticals raised a round of funding on April 20, 2016.

Wellesley Pharmaceuticals is in development of a patented drug for treating Nocturia (frequent urination at night). Currently there are no drugs on the market focused on nocturia and Wellesley plans t…

Articles about Wellesley Pharmaceuticals' Unattributed - II Round: